Today: 24 April 2026
Subscribe
Browse Category

NASDAQ:IBIO 21 October 2025 - 13 March 2026

ImmunityBio Stock Jumps After NK-Cell Manufacturing Update Puts Anktiva Expansion Back in Focus

ImmunityBio Stock Jumps After NK-Cell Manufacturing Update Puts Anktiva Expansion Back in Focus

ImmunityBio shares jumped 10.5% to $8.64 by early afternoon Friday after the company announced completion of a scalable manufacturing process for its NK-cell therapy platform. The update follows FDA acknowledgment of a resubmitted application for expanded use of Anktiva in papillary bladder cancer and recent approval of the drug in 33 countries. Investors remain cautious due to ongoing regulatory and financial risks.
13 March 2026
·
iBio (IBIO) Stock Jumps on Obesity Drug Momentum: All the Latest News, Analyst Targets and 2026–2027 Outlook (December 9, 2025)

iBio (IBIO) Stock Jumps on Obesity Drug Momentum: All the Latest News, Analyst Targets and 2026–2027 Outlook (December 9, 2025)

iBio, Inc. shares surged 39% Monday to close at $1.67 on heavy volume, lifting its market value to about $37.5 million. The stock traded higher pre-market Tuesday, with quotes between $1.76 and $1.81. The company reported $49.6 million in cash after a recent offering and says this will fund operations into late 2027. Lead obesity drug candidate IBIO-610 has shown fat-selective weight loss in animal studies.
9 December 2025
·
iBio Stock Surges on Bullish Analyst Calls and Obesity Drug Breakthroughs

iBio Stock Surges on Bullish Analyst Calls and Obesity Drug Breakthroughs

iBio (NASDAQ: IBIO) traded at $0.89 midday October 21, down 63% year-to-date from $2.45 in January. Shares jumped over 20% last week after bullish “Outperform” ratings from Oppenheimer and Leerink Partners, with price targets of $5.00 and $2.00. The company reported positive preclinical results for its obesity drug IBIO-610 and raised $50 million in a recent offering. Market cap stands near $18 million.
21 October 2025
·

Stock Market Today

  • JPMorgan downgrades Indian stocks to Neutral, warns Nifty could drop to 20,500
    April 24, 2026, 1:18 AM EDT. JPMorgan downgraded Indian stocks to Neutral, warning the Nifty 50 index could fall 15% to 20,500 amid stretched valuations and geopolitical risks linked to the Iran conflict. The brokerage cited near-term headwinds including energy supply disruptions and monsoon-related rural income risks impacting corporate earnings. It cut FY27 earnings estimates by 2-10% across sectors and lowered MSCI India EPS growth forecasts for 2026 and 2027. JPMorgan highlighted India's limited exposure to high-growth sectors like AI and semiconductors compared with other markets. The bank favors sectors such as Financials and Consumer Discretionary but remains underweight in IT and Pharma. HSBC also downgraded India due to inflation and energy price pressures, indicating a delayed economic recovery.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 24.04.2026

24 April 2026
Old Republic International closed at $39.90, below its estimated fair value of $42.50. The company is focusing on digitalization and AI to improve efficiency and margins. Risks include volatility in title insurance and weaker real estate activity. Market sentiment is mixed as investors assess growth prospects and challenges.
Newmont earnings today: Gold miner beats Q1 profit, adds $6 billion buyback but warns on Q2 costs

Newmont earnings today: Gold miner beats Q1 profit, adds $6 billion buyback but warns on Q2 costs

24 April 2026
Newmont reported adjusted first-quarter earnings of $2.90 per share on $7.31 billion in sales, beating estimates as realized gold prices surged to $4,900 an ounce. Attributable gold output fell to 1.30 million ounces from 1.54 million a year earlier. The miner declared a $0.26 dividend and authorized a new $6 billion share buyback. Newmont expects higher costs and lower output in the second quarter.
SAP Q1 Earnings Beat Forecasts as Cloud Revenue Climbs 27% in Constant Currencies, Outlook Holds

SAP Q1 Earnings Beat Forecasts as Cloud Revenue Climbs 27% in Constant Currencies, Outlook Holds

24 April 2026
SAP reported a 17% rise in first-quarter operating profit to 2.74 billion euros and a 19% jump in cloud revenue to 5.96 billion euros, beating forecasts. The company kept its 2026 targets and full-year outlook unchanged. SAP’s U.S. shares reversed losses after the results, climbing nearly 7% in after-hours trading. Management warned cloud revenue growth will slow in the second quarter.
Go toTop